134 related articles for article (PubMed ID: 25435189)
1. Epithelial-mesenchymal transition‑associated microRNAs in colorectal cancer and drug-targeted therapies (Review).
Jin D; Fang Y; Li Z; Chen Z; Xiang J
Oncol Rep; 2015 Feb; 33(2):515-25. PubMed ID: 25435189
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
3. Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy.
Bhangu A; Wood G; Mirnezami A; Darzi A; Tekkis P; Goldin R
Surg Oncol; 2012 Dec; 21(4):316-23. PubMed ID: 22981546
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in colorectal cancer metastasis.
de Krijger I; Mekenkamp LJ; Punt CJ; Nagtegaal ID
J Pathol; 2011 Aug; 224(4):438-47. PubMed ID: 21706478
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer.
Feng J; Fu Z; Guo J; Lu W; Wen K; Chen W; Wang H; Wei J; Zhang S
Mol Med Rep; 2014 Aug; 10(2):867-73. PubMed ID: 24920174
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs in colorectal carcinoma--from pathogenesis to therapy.
Chi Y; Zhou D
J Exp Clin Cancer Res; 2016 Mar; 35():43. PubMed ID: 26964533
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma.
Chen C; Zimmermann M; Tinhofer I; Kaufmann AM; Albers AE
Cancer Lett; 2013 Sep; 338(1):47-56. PubMed ID: 22771535
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis.
Hur K
BMB Rep; 2015 Apr; 48(4):217-22. PubMed ID: 25603797
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
Peng F; Fan H; Li S; Peng C; Pan X
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy.
Franco-Chuaire ML; Magda Carolina SC; Chuaire-Noack L
Invest Clin; 2013 Jun; 54(2):186-205. PubMed ID: 23947008
[TBL] [Abstract][Full Text] [Related]
12. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as Therapeutic Targets and Colorectal Cancer Therapeutics.
Yamamoto H; Mori M
Adv Exp Med Biol; 2016; 937():239-47. PubMed ID: 27573904
[TBL] [Abstract][Full Text] [Related]
14. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer.
Zhang N; Ng AS; Cai S; Li Q; Yang L; Kerr D
Lancet Oncol; 2021 Aug; 22(8):e358-e368. PubMed ID: 34339656
[TBL] [Abstract][Full Text] [Related]
15. New role of microRNA: carcinogenesis and clinical application in cancer.
Zhao L; Chen X; Cao Y
Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):831-9. PubMed ID: 21908856
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer.
Jafri MA; Zaidi SK; Ansari SA; Al-Qahtani MH; Shay JW
Expert Opin Ther Targets; 2015; 19(12):1705-23. PubMed ID: 26189482
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.
Foroni C; Broggini M; Generali D; Damia G
Cancer Treat Rev; 2012 Oct; 38(6):689-97. PubMed ID: 22118888
[TBL] [Abstract][Full Text] [Related]
18. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer.
Gurzu S; Silveanu C; Fetyko A; Butiurca V; Kovacs Z; Jung I
World J Gastroenterol; 2016 Aug; 22(30):6764-75. PubMed ID: 27570416
[TBL] [Abstract][Full Text] [Related]
19. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
20. Suppression of DACH1 promotes migration and invasion of colorectal cancer via activating TGF-β-mediated epithelial-mesenchymal transition.
Wang P
Biochem Biophys Res Commun; 2015 May; 460(2):314-9. PubMed ID: 25778865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
